• Opdivo-Yervoy Combo Showing Durable Benefits in Untreated Kidney Cancers in Long-term Trial
  • Potential CAR T-cell Therapy Targeting ROR1 Seen to Clear Cancer in Leukemia Mouse Model
  • Opdivo Extends Survival in Pretreated Advanced Stomach Cancer Patients, Phase 3 Trial Results Show
  • Ilixadencel Improves Responses, Extends Survival in Newly-diagnosed Metastatic Kidney Cancer, Trial Results Show
  • Pepinemab-Bavencio Combo Shows Positive Anti-Tumor Activity in Advanced Lung Cancer, Phase 1/2 Trial Shows
  • Geneos to Test GNOS-PV02 Cancer Vaccine in Triple Combo Trial for Advanced Liver Cancer
  • Bristol-Myers Squibb Withdraws European Application of Opdivo-Yervoy as Initial Treatment for Advanced NSCLC
  • First Patient Dosed in Proof-of-concept Study of CS1001 Plus Stivarga for Advanced Solid Tumors
  • Newly Discovered T-cell Receptor May Lead to More ‘Universal’ Cancer Therapy, Study Suggests
  • Cabometyx, Opdivo, Yervoy Triple Combo Shows Potential Benefits in Advanced HCC, Trial Data Show
  • NeoImmuneTech Cleared to Test Hyleukin-7, Keytruda Combo in Trial for Advanced Solid Tumors
  • FDA to Review Tecentriq-Avastin Combo for Newly Diagnosed Advanced Liver Cancers